← Scroll for more →
Evolus, Inc. (EOLS)
Pharmaceutical Preparations
Latest Price
$7.35
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
0.09
P/B Ratio
84.29
Institutional Ownership
75.1% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 5.60M | $38.0M | 8.49% | -774.8K | 2026-06-30 |
| BlackRock, Inc. | 4.84M | $33.0M | 7.33% | +550.4K | 2026-06-30 |
| Braidwell LP | 3.16M | $21.0M | 4.78% | +50.0K | 2026-06-30 |
| Frazier Life Sciences Management, L.P. | 2.63M | $18.0M | 3.99% | -- | 2026-06-30 |
| Perceptive Advisors LLC | 2.46M | $17.0M | 3.73% | +1.17M | 2026-06-30 |
| Vanguard Capital Management LLC | 2.36M | $16.0M | 3.58% | -107.5K | 2026-06-30 |
| Stonepine Capital Management, LLC | 2.01M | $14.0M | 3.05% | -168.9K | 2026-06-30 |
| Millennium Management LLC | 1.79M | $12.0M | 2.71% | +326.8K | 2026-06-30 |
| State Street Corp | 1.70M | $11.0M | 2.57% | +376.5K | 2026-06-30 |
| Geode Capital Management, LLC | 1.61M | $11.0M | 2.44% | +227.1K | 2026-06-30 |